Risperidone Exacerbates Glucose Intolerance, Nonalcoholic Fatty Liver Disease, and Renal Impairment in Obese Mice

Risperidone, a second-generation antipsychotic drug used for schizophrenia treatment with less-severe side effects, has recently been applied in major depressive disorder treatment. The mechanism underlying risperidone-associated metabolic disturbances and liver and renal adverse effects warrants fu...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Int J Mol Sci
Hlavní autoři: Tsai, Hsiao-Pei, Hou, Po-Hsun, Mao, Frank-Chiahung, Chang, Chia-Chia, Yang, Wei-Cheng, Wu, Ching-Feng, Liao, Huei-Jyuan, Lin, Tzu-Chun, Chou, Lan-Szu, Hsiao, Li-Wei, Chang, Geng-Ruei
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI 2021
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7795724/
https://ncbi.nlm.nih.gov/pubmed/33401717
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms22010409
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky